• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霉酚酸酯致系统性硬化症患者结肠炎

Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.

作者信息

Moroncini Gianluca, Benfaremo Devis, Mandolesi Alessandra, Gabrielli Armando

机构信息

Dipartimento Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy.

Clinica Medica, AOU Ospedali Riuniti di Ancona, Ancona, Italy.

出版信息

BMJ Case Rep. 2018 May 18;2018:bcr-2018-224829. doi: 10.1136/bcr-2018-224829.

DOI:10.1136/bcr-2018-224829
PMID:29776943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5965754/
Abstract

We present the case of a 44-year-old woman affected by systemic sclerosis (SSc) who was admitted to our department for abdominal pain, nausea, vomiting and fever. Imaging studies showed the presence of a thickened colon wall involving the descending colon and the sigma, while a subsequent endoscopy revealed multiple serpiginous ulcers covered with fibrin and exudates. Under the hypothesis of drug-induced colitis, mycophenolate mofetil (MMF), which she was taking for SSc-related interstitial lung disease (ILD), was readily suspended, with a rapid recovery without further treatment. A follow-up colonoscopy showed the complete resolution of the ulcers. This is the first case of MMF-induced colitis in a patient being treated for SSc-ILD.

摘要

我们报告了一例44岁患有系统性硬化症(SSc)的女性病例,该患者因腹痛、恶心、呕吐和发热入住我科。影像学检查显示降结肠和乙状结肠肠壁增厚,随后的内镜检查发现多处匐行性溃疡,表面覆盖有纤维蛋白和渗出物。在药物性结肠炎的假设下,她因SSc相关间质性肺病(ILD)正在服用的霉酚酸酯(MMF)被立即停用,未经进一步治疗便迅速康复。随访结肠镜检查显示溃疡完全愈合。这是首例在接受SSc-ILD治疗的患者中发生MMF诱导性结肠炎的病例。

相似文献

1
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.霉酚酸酯致系统性硬化症患者结肠炎
BMJ Case Rep. 2018 May 18;2018:bcr-2018-224829. doi: 10.1136/bcr-2018-224829.
2
Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis.霉酚酸酯作为系统性硬化症间质性肺疾病的治疗药物。
Respir Investig. 2018 Jan;56(1):14-20. doi: 10.1016/j.resinv.2017.11.004. Epub 2017 Dec 6.
3
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.霉酚酸酯是治疗系统性硬化症相关间质性肺病的一种有效且安全的选择:澳大利亚硬皮病队列研究结果
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):170-176. Epub 2016 Mar 24.
4
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.环磷酰胺与霉酚酸酯用于硬皮病间质性肺病(SSc-ILD)诱导治疗的单中心回顾性分析
Arthritis Res Ther. 2016 Jun 2;18(1):123. doi: 10.1186/s13075-016-1015-0.
5
Use of mycophenolate mofetil for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database.霉酚酸酯治疗系统性硬化症和系统性硬化症相关间质性肺病:来自日本医院索赔数据库的信息。
Mod Rheumatol. 2022 Jul 1;32(4):755-760. doi: 10.1093/mr/roab111.
6
[Importance of mycophenolate mofetil for treatment of interstitial lung disease in systemic sclerosis].霉酚酸酯在系统性硬化症间质性肺疾病治疗中的重要性
Z Rheumatol. 2021 Nov;80(9):868-878. doi: 10.1007/s00393-021-01088-y. Epub 2021 Sep 20.
7
Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series.霉酚酸酯治疗硬皮病肺病患者的两年经验:病例系列
Int J Rheum Dis. 2014 Nov;17(8):923-8. doi: 10.1111/1756-185X.12399. Epub 2014 May 26.
8
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.系统性硬皮病肺研究 II 中免疫抑制后 CT 定量间质性肺病的纵向变化。
Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC.
9
Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience.霉酚酸酯治疗硬皮病相关间质性肺疾病:一项真实世界经验。
PLoS One. 2017 May 25;12(5):e0177107. doi: 10.1371/journal.pone.0177107. eCollection 2017.
10
Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease.霉酚酸酯治疗系统性硬皮病相关的间质性肺疾病。
Clin Rheumatol. 2010 Oct;29(10):1167-8. doi: 10.1007/s10067-010-1498-z. Epub 2010 Jun 10.

引用本文的文献

1
Mycophenolate Mofetil Induced-Colitis: Is it More about Clinical Diagnosis?霉酚酸酯诱导的结肠炎:更多关乎临床诊断?
Curr Drug Saf. 2025;20(4):498-500. doi: 10.2174/0115748863318109241104111738.
2
Mycophenolate-induced colitis in a patient with lupus nephritis: a case report and review of the literature.狼疮性肾炎患者霉酚酸酯相关性结肠炎:病例报告及文献复习。
J Med Case Rep. 2024 May 1;18(1):229. doi: 10.1186/s13256-024-04539-7.
3
Mycophenolate Induced Colitis: One-year Post-kidney Transplantation.霉酚酸酯诱发的结肠炎:肾移植术后一年
Oman Med J. 2023 Mar 31;38(2):e489. doi: 10.5001/omj.2023.14. eCollection 2023 Mar.
4
Mycophenolate-Induced Colitis in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients.自身免疫性多内分泌腺病-念珠菌病-外胚层营养不良患者中的霉酚酸酯诱导的结肠炎
JPGN Rep. 2021 Nov;2(4):e131. doi: 10.1097/pg9.0000000000000131.
5
Secondary causes of inflammatory bowel diseases.炎症性肠病的继发原因。
World J Gastroenterol. 2020 Jul 28;26(28):3998-4017. doi: 10.3748/wjg.v26.i28.3998.
6
Mycophenolate-induced Colitis: A Case Report with Focused Review of Literature.霉酚酸酯诱发的结肠炎:一例病例报告并文献综述
Cureus. 2020 Jan 25;12(1):e6774. doi: 10.7759/cureus.6774.
7
Colitis and Pancreatitis in a Patient with Systemic Lupus Erythematosus: Due to Disease or to Drug?系统性红斑狼疮患者的结肠炎和胰腺炎:病因是疾病还是药物?
Dig Dis Sci. 2018 Sep;63(9):2206-2209. doi: 10.1007/s10620-018-5225-y.

本文引用的文献

1
Gastrointestinal Manifestations of Systemic Sclerosis.系统性硬化症的胃肠道表现
J Scleroderma Relat Disord. 2016;1(3):247-256. doi: 10.5301/jsrd.5000214. Epub 2016 Oct 18.
2
Update of EULAR recommendations for the treatment of systemic sclerosis.EULAR 系统性硬皮病治疗推荐更新。
Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.
3
Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences.巨细胞病毒性结肠炎、巨细胞病毒性肝炎及全身性巨细胞病毒感染:共同特征与差异
Inflamm Intest Dis. 2016 Apr;1(1):15-23. doi: 10.1159/000443198. Epub 2016 Jan 23.
4
Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation.实体器官移植术后患者霉酚酸酯结肠炎的内镜及组织学特征
Ann Gastroenterol. 2015 Jul-Sep;28(3):366-373.
5
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?我们在系统性硬化症患者间质性肺病的管理中走向何方?
Autoimmun Rev. 2015 Jul;14(7):575-8. doi: 10.1016/j.autrev.2015.02.002. Epub 2015 Feb 21.
6
Collagenous colitis in systemic sclerosis: an overlooked and treatable complication.
J Clin Rheumatol. 2014 Aug;20(5):278-82. doi: 10.1097/RHU.0000000000000121.
7
Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis.结肠活检的组织学特征可区分霉酚酸酯与移植物抗宿主病相关性结肠炎。
Am J Surg Pathol. 2013 Sep;37(9):1319-28. doi: 10.1097/PAS.0b013e31829ab1ef.
8
Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil.接受霉酚酸酯治疗的患者结肠活检组织学变化谱
Mod Pathol. 2009 Jun;22(6):737-43. doi: 10.1038/modpathol.2009.44. Epub 2009 Mar 27.
9
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies.
Swiss Med Wkly. 2009 Jan 24;139(3-4):41-6. doi: 10.4414/smw.2009.12441.